Xtant Medical Holdings Inc (XTNT):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Xtant Medical Holdings Inc (XTNT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3506
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowrap, orbitalwrap HD, facet stabilization, milled cervical spacers, traditional allografts, hMatrix ADM, hMatrix PR ADM, and sports medicine. It utilizes sterile technology for manufacturing bacterin products. The company offers its products for the treatment of degenerative, traumatic, and deformity conditions for orthopedic and neurological applications. It operates in Louisiana, Maryland, Oregon, Illinois, Delaware, California, Florida, and New York. Xtant Medical is headquartered in Belgrade, Montana, the US.

Xtant Medical Holdings Inc (XTNT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Xtant Medical Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
Xtant Medical to Raise up to USD8.2 Million in Rights Offering of Shares 11
Bacterin International Raises USD6.5 Million in Public Offering of Shares 12
Bacterin International Completes Private Placement Of Shares For US$4 Million 14
Bacterin International Completes Private Placement Of Shares For US$4.8 Million 15
Bacterin International Completes Private Placement Of Shares For US$3.9 Million 16
Debt Offering 17
Bacterin International Raises USD65 Million in Private Placement of 6% Notes Due 2021 17
Xtant Medical Holdings Inc – Key Competitors 18
Xtant Medical Holdings Inc – Key Employees 19
Xtant Medical Holdings Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Strategy And Business Planning 21
Oct 06, 2017: Xtant Medical Announces Consolidation of Fixation Operations to Montana and Closure of Dayton Facility 21
Financial Announcements 22
Aug 07, 2018: Xtant Medical announces second quarter 2018 financial results 22
May 08, 2018: Xtant Medical Announces First Quarter 2018 Financial Results 24
Apr 02, 2018: Xtant Announces Fourth Quarter and Year End 2017 Financial Results 26
Nov 21, 2017: Xtant Medical Reports Third Quarter 2017 Financial Results 29
Aug 09, 2017: Xtant Medical Reports Second Quarter 2017 Financial Results 31
May 09, 2017: Xtant Medical Reports First Quarter Revenue of $22.1 million, 5% Growth Compared to the Prior Year Period 32
Mar 09, 2017: Xtant Medical Reports Record Fourth Quarter Revenue of $24.5 million, 10% Growth Compared to Prior Year Period 33
Jan 11, 2017: XTNT Announces Preliminary Fourth Quarter and Full Year 2016 Revenue & Adjusted EBITDA 35
Corporate Communications 36
Aug 20, 2018: Xtant Medical appoints Kathie Lenzen as Chief Financial Officer 36
Jul 10, 2018: Xtant Medical Names Kevin Brandt As Chief Commercial Officer 37
Feb 22, 2017: Xtant Medical Announces Appointment of Carl O’Connell to Permanent CEO 38
Jan 23, 2017: Xtant Medical CEO Dan Goldberger announces resignation 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Xtant Medical Holdings Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Xtant Medical Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Xtant Medical to Raise up to USD8.2 Million in Rights Offering of Shares 11
Bacterin International Raises USD6.5 Million in Public Offering of Shares 12
Bacterin International Completes Private Placement Of Shares For US$4 Million 14
Bacterin International Completes Private Placement Of Shares For US$4.8 Million 15
Bacterin International Completes Private Placement Of Shares For US$3.9 Million 16
Bacterin International Raises USD65 Million in Private Placement of 6% Notes Due 2021 17
Xtant Medical Holdings Inc, Key Competitors 18
Xtant Medical Holdings Inc, Key Employees 19
Xtant Medical Holdings Inc, Subsidiaries 20

List of Figures
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Xtant Medical Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Xtant Medical Holdings Inc (XTNT):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lotte Holdings Co. Ltd.:企業の戦略・SWOT・財務情報
    Lotte Holdings Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Lotte Holdings Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sichuan Chuantou Energy Company Ltd (600674):電力:M&Aディール及び事業提携情報
    Summary Sichuan Chuantou Energy Company Ltd (Sichuan Investment Energy), a subsidiary of Sichuan Investment Group Co Ltd is an investment holding company. The company’s business activities include operation of hydropower stations, thermal power plant and power generation plants. It develops, constru …
  • Kubota Corporation (6326):企業の財務・戦略的SWOT分析
    Kubota Corporation (6326) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • China Haisheng Juice Holdings Co Ltd:企業の戦略・SWOT・財務情報
    China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Cerner Corporation:企業の戦略・SWOT・財務情報
    Cerner Corporation - Strategy, SWOT and Corporate Finance Report Summary Cerner Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • GeneNews Ltd (GEN):企業の財務・戦略的SWOT分析
    Summary GeneNews Ltd (GeneNews) is a provider of molecular diagnostic products. The company develops and commercializes diagnostics and personalized medicine for cancer and other chronic diseases. Its Sentinel Principle is a novel approach to identifying biomarkers of body state using blood. GeneNew …
  • Visiomed Group SA (ALVMG):医療機器:M&Aディール及び事業提携情報
    Summary Visiomed Group SA (Visiomed) is a medical device company. The company develops and distributes electronic medical devices. It offers screening and diagnosis products, pain relief products, prevention and treatment products, hearing and optics, family hygiene, children’s optics, baby bottle t …
  • Insurance Australia Group Limited:企業の戦略・SWOT・財務情報
    Insurance Australia Group Limited - Strategy, SWOT and Corporate Finance Report Summary Insurance Australia Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Discount Tire Co.:企業の戦略・SWOT・財務情報
    Discount Tire Co. - Strategy, SWOT and Corporate Finance Report Summary Discount Tire Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Carondelet Health Network-製薬・医療分野:企業M&A・提携分析
    Summary Carondelet Health Network (Carondelet) is a healthcare service organization that serves through its network of hospitals including St. Mary’s Hospital, St. Joseph’s Hospital and Holy Cross Hospital. The organization provides a wide range of medical and treatment services such as neurology or …
  • Simon Property Group, Inc.:企業の戦略・SWOT・財務情報
    Simon Property Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Simon Property Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Cosmo Bio Co Ltd (3386):企業の財務・戦略的SWOT分析
    Summary Cosmo Bio Co Ltd (Cosmo Bio) operates as a medical device company that offers markets research reagents and research instruments. The company’s product categories include antibodies, assay and detection, cells and cell culture, bioactive substances, protein engineering, separation and purifi …
  • Chr. Hansen Holding AS (CHR):企業の財務・戦略的SWOT分析
    Chr. Hansen Holding AS (CHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Lantheus Medical Imaging Inc:医療機器:M&Aディール及び事業提携情報
    Summary Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures, and commercializes diagnostic imaging agents and products for the diagnosis of conditions that affect heart, brain, lungs and other organs using echocardiography and nuclear imag …
  • Celdara Medical LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Celdara Medical LLC (Celdara Medical) is a biotechnology company that helps transform academic innovations into medicines to cure serious diseases. It provides pipeline development services, and has a pipeline of anti-inflammatory therapeutics, latent HIV elimination, idiopathic pulmonary fi …
  • China Haisheng Juice Holdings Co Ltd:企業の戦略・SWOT・財務分析
    China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Sirtex Medical Ltd (SRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Sirtex Medical Ltd (Sirtex Medical) is a medical device company that develops and markets device for the treatment of liver cancer. The company’s sir-spheres microsphere is a medical device, which is used in selective internal radiation therapy for liver tumors. Its product Y-90 resin micros …
  • Sabre Corporation (SABR):企業の財務・戦略的SWOT分析
    Sabre Corporation (SABR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Verbund AG (VER):電力:M&Aディール及び事業提携情報
    Summary Verbund AG (Verbund) is an electricity utility that generates, transmits, trades, and distributes electricity. It generates from renewable energy sources such as hydropower, biomass, wind, and solar power. The company constructs, operates and maintains power plants; trades electricity and ga …
  • Hey-Song Corporation:戦略・SWOT・企業財務分析
    Hey-Song Corporation - Strategy, SWOT and Corporate Finance Report Summary Hey-Song Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆